Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-032078

Chief Executive Officer sold 30,000 shares at an average $34.58 ($1,037,361)

From the SEC's structured data for this filing

Trades in this filing

Lynch Casey · Chief Executive Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-05-10 Sale : show line 1 in the form −13,584 $33.75 $458,460 995,190 I
2021-05-10 Sale : show line 2 in the form −9,918 $34.89 $346,039 985,272 I
2021-05-10 Sale : show line 3 in the form −6,315 $35.81 $226,140 978,957 I
2021-05-10 Sale : show line 4 in the form −183 $36.73 $6,722 978,774 I
Open-market sales · 30,000 sh · avg $34.58 · $1,037,361
Loading xslF345X03/doc4.xml…